WO2004014341A1 - Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif - Google Patents
Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif Download PDFInfo
- Publication number
- WO2004014341A1 WO2004014341A1 PCT/KR2003/001266 KR0301266W WO2004014341A1 WO 2004014341 A1 WO2004014341 A1 WO 2004014341A1 KR 0301266 W KR0301266 W KR 0301266W WO 2004014341 A1 WO2004014341 A1 WO 2004014341A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- florfenicol
- pharmaceutical composition
- oral administration
- surfactant
- administration according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Definitions
- the present invention relates to a pharmaceutical composition comprising florfenicol as an active ingredient, and more particularly to a pharmaceutical composition for oral administration comprising a florfenicol-containing microemulsion as an effective ingredient which is obtained by adding an oil and a surfactant to a solution of florfenicol in a hydrophilic or amphiphilic dispersion medium.
- a pharmaceutical composition for oral administration comprising a florfenicol- containing microemulsion as an effective ingredient wherein the microemulsion is obtained by adding an oil and a surfactant to a solution of florfenicol in a hydrophilic or amphiphilic dispersion medium.
- microemulsion containing florfenicol as an active ingredient enables the provision of the pharmaceutical composition comprising the active ingredient in the high concentration with excellent bioavailability in which the concentration of the active ingredient can be easily controlled by drinking water upon oral administration.
- the hydrophilic or amphiphilic solvent as a dispersion medium is at least one solvent selected from the group consisting of diethyleneglycol monoethylether,
- the weight ratio of the florfenicol to the hydrophilic or amphiphilic solvent is preferably within the range of 1: 0.5 ⁇ 5, and more preferably 1: 1 ⁇ 3.
- the surfactant preferably has a hydrophilic lipophlic balance (HLB) of 1 ⁇ 20.
- the surfactant usable in the present invention is at least one compound selected from the group consisting of reaction products between vegetable hardened oils and ethylene glycol (e.g., Cremophor RH40, Cremophor RH60); polyethylene sorbitan fatty acid esters (e.g., Tween 20, Tween 40); polyoxyethylene fatty acid esters; polyoxyethylene-polyoxypropylene copolymers; and ester group transfer reaction products between vegetable oil triglycerides and polyalkylenepolyols (e.g., Labrafil, Labrasol).
- the surfactant includes polyethyleneglycol 40 castor hardened oil and polyethyleneglycol 35 castor hardened oil.
- the oil used in the present invention is at least one compound selected from the group consisting of vegetable oils, esterification products of vegetable oils and highly unsaturated fatty acids.
- the weight ratio of the florfenicol to the oil is preferably within the range of 1: 0.1 ⁇ 10, and more preferably 1: 0.5 ⁇ 3. When the ratio is less than 1: 0.1, addition effect of the oil is none or little. When the ratio exceeds 1 : 10, there is a risk of phase separation.
- this range is given only for the purpose of illustration, and is not to be construed as limiting the scope ofthe invention.
- the pharmaceutical composition for oral administration of the present invention comprising the florfenicol-containing microemulsion may further comprise various medically acceptable additives.
- these additives include antioxidants (butylparahydroxy benzoic acid, butylhydroquinone, tocopherol, etc.), viscosity enhancing agents (sodium alginate, carboxymethylcellulose, methylcellulose, tragacanth, agar, polyvinylpyrrolidone, etc.), aromatics (orange oil, peppermint, vanilla, cocoa, etc.), preservative agents (methyl paraoxybenzoate, propyl paraoxybenzoate, sodium benzoylbenzoate, benzalkonium chloride, etc), colorants (Red #40, Yellow #4, Green #3, Blue #1), and the like.
- antioxidants butylparahydroxy benzoic acid, butylhydroquinone, tocopherol, etc.
- viscosity enhancing agents sodium alginate, carboxymethylcellulose, methylcellulose, trag
- Fig. 1 is a graph showing the concentration of an active ingredient in blood, measured at predetermined time intervals after a pharmaceutical composition of the present invention is orally administered into male rats.
- the pharmaceutical composition for oral administration according to the present invention comprises a high concentration active ingredient with excellent bioavailability in which the concentration of the active ingredient can be easily controlled by drinking water upon oral administration.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003244259A AU2003244259A1 (en) | 2002-08-13 | 2003-06-27 | Oral injectable pharmaceutical composition comprising florfenicol as an active ingredient |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020047910A KR20040015624A (ko) | 2002-08-13 | 2002-08-13 | 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물 |
KR10-2002-0047910 | 2002-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004014341A1 true WO2004014341A1 (fr) | 2004-02-19 |
Family
ID=31713128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2003/001266 WO2004014341A1 (fr) | 2002-08-13 | 2003-06-27 | Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20040015624A (fr) |
AU (1) | AU2003244259A1 (fr) |
WO (1) | WO2004014341A1 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009019604A2 (fr) * | 2007-08-09 | 2009-02-12 | Ems S/A | Systèmes d'administration pour solubiliser des principes actifs pharmaceutiques insolubles dans l'eau. |
FR2925335A1 (fr) * | 2007-12-21 | 2009-06-26 | Ceva Sante Animale Sa | Compositions orales liquides de florfenicol diluables dans l'eau de boisson |
FR2925855A1 (fr) * | 2007-12-26 | 2009-07-03 | Virbac Sa Sa | Composition liquide autoemulsionnable de florfenicol destinee a etre incorporee a l'eau de boisson des animaux d'elevage. |
AU2005318187B2 (en) * | 2004-12-21 | 2010-12-16 | Intervet International B.V. | Injectable veterinary composition |
CN106236705A (zh) * | 2016-08-30 | 2016-12-21 | 瑞普(天津)生物药业有限公司 | 一种可用于饮水给药的氟苯尼考溶液剂及其制备方法 |
CN109125262A (zh) * | 2018-09-11 | 2019-01-04 | 江苏农牧科技职业学院 | 氟苯尼考纳米乳及其制备方法 |
US10905759B2 (en) | 2016-08-19 | 2021-02-02 | Sementis Limited | Vector-based attenuated poxvirus vaccines |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004016A1 (fr) * | 1990-08-29 | 1992-03-19 | Schering Corporation | Composition pharmaceutique de florfenicol |
US5932243A (en) * | 1993-05-27 | 1999-08-03 | Novartis Ag | Galenical formulations |
-
2002
- 2002-08-13 KR KR1020020047910A patent/KR20040015624A/ko active IP Right Grant
-
2003
- 2003-06-27 WO PCT/KR2003/001266 patent/WO2004014341A1/fr not_active Application Discontinuation
- 2003-06-27 AU AU2003244259A patent/AU2003244259A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004016A1 (fr) * | 1990-08-29 | 1992-03-19 | Schering Corporation | Composition pharmaceutique de florfenicol |
US5932243A (en) * | 1993-05-27 | 1999-08-03 | Novartis Ag | Galenical formulations |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005318187B2 (en) * | 2004-12-21 | 2010-12-16 | Intervet International B.V. | Injectable veterinary composition |
GB2451811A (en) * | 2007-08-09 | 2009-02-18 | Ems Sa | Delivery composition for solubilising water-insoluble pharmaceutical active ingredients |
US9278065B2 (en) | 2007-08-09 | 2016-03-08 | Ems S/A | Delivery systems for solubilising water-insoluble pharmaceutical active ingredients |
US20120177692A1 (en) * | 2007-08-09 | 2012-07-12 | Ems S/A | Delivery systems for solubilising water-insoluble pharmaceutical active ingredients |
WO2009019604A2 (fr) * | 2007-08-09 | 2009-02-12 | Ems S/A | Systèmes d'administration pour solubiliser des principes actifs pharmaceutiques insolubles dans l'eau. |
WO2009019604A3 (fr) * | 2007-08-09 | 2009-07-23 | Ems Sa | Systèmes d'administration pour solubiliser des principes actifs pharmaceutiques insolubles dans l'eau. |
WO2009083520A2 (fr) * | 2007-12-21 | 2009-07-09 | Ceva Sante Animale | Compositions orales liquides de florfenicol diluables dans l'eau de boisson |
WO2009083520A3 (fr) * | 2007-12-21 | 2009-12-03 | Ceva Sante Animale | Compositions orales liquides de florfenicol diluables dans l'eau de boisson |
FR2925335A1 (fr) * | 2007-12-21 | 2009-06-26 | Ceva Sante Animale Sa | Compositions orales liquides de florfenicol diluables dans l'eau de boisson |
WO2009106714A3 (fr) * | 2007-12-26 | 2009-12-17 | Virbac Sa | Composition liquide autoemuls ionnable de florfeni col destinee a etre incorporee a l'eau de boisson des animaux d'elevage |
WO2009106714A2 (fr) | 2007-12-26 | 2009-09-03 | Virbac Sa | Composition liquide autoemuls ionnable de florfeni col destinee a etre incorporee a l'eau de boisson des animaux d'elevage |
US20110028560A1 (en) * | 2007-12-26 | 2011-02-03 | Virbac Sa | Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock |
FR2925855A1 (fr) * | 2007-12-26 | 2009-07-03 | Virbac Sa Sa | Composition liquide autoemulsionnable de florfenicol destinee a etre incorporee a l'eau de boisson des animaux d'elevage. |
US9339460B2 (en) | 2007-12-26 | 2016-05-17 | Virbac Sa | Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock |
US10905759B2 (en) | 2016-08-19 | 2021-02-02 | Sementis Limited | Vector-based attenuated poxvirus vaccines |
CN106236705A (zh) * | 2016-08-30 | 2016-12-21 | 瑞普(天津)生物药业有限公司 | 一种可用于饮水给药的氟苯尼考溶液剂及其制备方法 |
CN109125262A (zh) * | 2018-09-11 | 2019-01-04 | 江苏农牧科技职业学院 | 氟苯尼考纳米乳及其制备方法 |
CN109125262B (zh) * | 2018-09-11 | 2020-12-25 | 江苏农牧科技职业学院 | 氟苯尼考纳米乳及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20040015624A (ko) | 2004-02-19 |
AU2003244259A1 (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI119175B (fi) | Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi | |
EP0715856B1 (fr) | Composition antifongique stockable dans la keratine pour usage externe | |
EP0515310B1 (fr) | Composition topique de terbinafine | |
CA2294033C (fr) | Composition pharmaceutique pour composes acides lipophiles sous forme d'une formulation autoemulsifiante | |
US4849418A (en) | Transdermally absorbable water-containing preparations of arylpropionic acid derivatives and process for preparing same | |
JPH0345044B2 (fr) | ||
WO2004014341A1 (fr) | Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif | |
AU3495093A (en) | Liposomal piroxicam formulations | |
CA2074503C (fr) | Formulation pharmaceutique contenant du penciclovir | |
WO2004014340A1 (fr) | Composition injectable comprenant du florfenicol comme principe actif | |
WO2018060870A1 (fr) | Composition pharmaceutique de l'ivermectine et son procédé de préparation | |
KR100342945B1 (ko) | 항진균제의 외용 약제 조성물 및 이의 제조방법 | |
ES2325373T3 (es) | Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida. | |
CN100386074C (zh) | 维甲酸或其类似物口服制剂 | |
JP4734910B2 (ja) | 難水溶性薬剤用可溶化剤組成物 | |
JPH0366618A (ja) | 薬学的配合物 | |
EP0021847B1 (fr) | Compositions injectables de sulfonamide à effet prolongé | |
JPH04356420A (ja) | チアミン・コバルト・クロロフィリン錯化合物含有組成物 | |
GB1593354A (en) | Liquid pharmaceutical formulations | |
WO1995017179A1 (fr) | Preparation dermatologique stable contenant de l'acide mycophenolique | |
JPS63146817A (ja) | 外用抗真菌剤 | |
EP0625898B1 (fr) | Formulations liposomiques au piroxicam | |
JP2894843B2 (ja) | 外用抗炎症剤 | |
WO2021099901A1 (fr) | Composition pharmaceutique topique stable | |
WO2010102991A2 (fr) | Émulsions de riluzole liquides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |